Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Author Title [ Type(Desc)] Year
Filters: Keyword is Animals  [Clear All Filters]
Journal Article
Schnabel R, Metzger M, Jiang S, Hemmings HC, Greengard P, Braun K.  1997.  Localization of dopamine D1 receptors and dopaminoceptive neurons in the chick forebrain.. J Comp Neurol. 388(1):146-68.
Solovey G, Alonso LM, Yanagawa T, Fujii N, Magnasco MO, Cecchi GA, Proekt A.  2015.  Loss of Consciousness Is Associated with Stabilization of Cortical Activity.. J Neurosci. 35(30):10866-77.
Watson SL, McCoy JG, M Fontenot B, Hanbury DB, Ward CP.  2009.  L-tryptophan and correlates of self-injurious behavior in small-eared bushbabies (Otolemur garnettii).. J Am Assoc Lab Anim Sci. 48(2):185-91.
King MM, Huang CY, Chock PB, Nairn AC, Hemmings HC, Chan KF, Greengard P.  1984.  Mammalian brain phosphoproteins as substrates for calcineurin.. J Biol Chem. 259(13):8080-3.
Ryan TA, Reuter H.  2001.  Measurements of vesicle recycling in central neurons.. News Physiol Sci. 16:10-4.
Picollo A, Liantonio A, Babini E, Camerino DConte, Pusch M.  2007.  Mechanism of interaction of niflumic acid with heterologously expressed kidney CLC-K chloride channels.. J Membr Biol. 216(2-3):73-82.
Heerdt PM, Caldwell RW.  1989.  The mechanism of nitrous oxide-induced changes in pulmonary vascular resistance in a dog model of left atrial outflow obstruction.. J Cardiothorac Anesth. 3(5):568-73.
Pusch M, Accardi A, Liantonio A, Guida P, Traverso S, Camerino DConte, Conti F.  2002.  Mechanisms of block of muscle type CLC chloride channels (Review).. Mol Membr Biol. 19(4):285-92.
Naguib M, Gottumukkala V, Goldstein PA.  2007.  Melatonin and anesthesia: a clinical perspective.. J Pineal Res. 42(1):12-21.
Ward CP, Harsh JR, York KM, Stewart KL, McCoy JG.  2004.  Modafinil facilitates performance on a delayed nonmatching to position swim task in rats.. Pharmacol Biochem Behav. 78(4):735-41.
Surmeier DJ, Bargas J, Hemmings HC, Nairn AC, Greengard P.  1995.  Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons.. Neuron. 14(2):385-97.
Jia F, Goldstein PA, Harrison NL.  2009.  The modulation of synaptic GABA(A) receptors in the thalamus by eszopiclone and zolpidem.. J Pharmacol Exp Ther. 328(3):1000-6.
Dittman J, Ryan TA.  2009.  Molecular circuitry of endocytosis at nerve terminals.. Annu Rev Cell Dev Biol. 25:133-60.
Ryan TA, Myers J, Holowka D, Baird B, Webb WW.  1988.  Molecular crowding on the cell surface.. Science. 239(4835):61-4.
Liantonio A, Accardi A, Carbonara G, Fracchiolla G, Loiodice F, Tortorella P, Traverso S, Guida P, Pierno S, De Luca A et al..  2002.  Molecular requisites for drug binding to muscle CLC-1 and renal CLC-K channel revealed by the use of phenoxy-alkyl derivatives of 2-(p-chlorophenoxy)propionic acid.. Mol Pharmacol. 62(2):265-71.
Liantonio A, Picollo A, Carbonara G, Fracchiolla G, Tortorella P, Loiodice F, Laghezza A, Babini E, Zifarelli G, Pusch M et al..  2008.  Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.. Proc Natl Acad Sci U S A. 105(4):1369-73.
Agnati LF, Fuxe K, Zoli M, Ferraguti F, Benfenati F, Ouimet CC, Walaas SI, Hemmings HC, Goldstein M, Greengard P.  1988.  Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.. Neuroscience. 27(3):785-97.
Proekt A, Jing J, Weiss KR.  2007.  Multiple contributions of an input-representing neuron to the dynamics of the aplysia feeding network.. J Neurophysiol. 97(4):3046-56.
Mitchell SJ, Ryan TA.  2005.  Munc18-dependent regulation of synaptic vesicle exocytosis by syntaxin-1A in hippocampal neurons.. Neuropharmacology. 48(3):372-80.
Baba H, Kohno T, Okamoto M, Goldstein PA, Shimoji K, Yoshimura M.  1998.  Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn.. J Physiol. 508 ( Pt 1):83-93.
Ryan TA.  2001.  NCAM and vesicle cycling: the importance of good glue in the long run.. Neuron. 32(5):759-61.
Lien CA.  2010.  Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent? Anesthesiology. 112(1):16-8.
Boros EE, Samano V, Ray JA, Thompson JB, Jung DK, Kaldor I, Koble CS, Martin MT, Styles VL, Mook RA et al..  2003.  Neuromuscular blocking activity and therapeutic potential of mixed-tetrahydroisoquinolinium halofumarates and halosuccinates in rhesus monkeys.. J Med Chem. 46(12):2502-15.
Ginsburg S, Kitz RJ, Savarese JJ.  1971.  Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.. Br J Pharmacol. 43(1):107-26.
Okamoto M, Walewski JL, Artusio JF, Riker WF.  1992.  Neuromuscular pharmacology in rat neonates: development of responsiveness to prototypic blocking and reversal drugs.. Anesth Analg. 75(3):361-71.